Who is sponsoring NCT02794493?

NCT02794493 is sponsored by China-Japan Friendship Hospital.

What condition does NCT02794493 study?

NCT02794493 studies Hand Foot Syndrome.

What drugs are being tested in NCT02794493?

Interventions: Traditional Chinese Medicine Formula LC09, Placebo.

What is the status of NCT02794493?

NCT02794493 is currently COMPLETED.

Last reviewed 2019-07-25 · How we verify

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

NCT02794493 PHASE3 COMPLETED

RATIONALE: Hand foot syndrome may be treated or reduced by soaking Traditional Chinese Medicine Formula LC09 in patients receiving capecitabine for colorectal and/or breast cancer. PURPOSE: This randomized phase III trial is studying soaking Traditional Chinese Medicine Formula LC09 to see how well they work compared to placebos in preventing hand-foot syndrome in patients who are receiving capecitabine for colorectal or breast cancer.

Details

Lead sponsor	China-Japan Friendship Hospital
Phase	PHASE3
Status	COMPLETED
Enrolment	156
Start date	Wed Apr 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Apr 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Hand Foot Syndrome

Interventions

Traditional Chinese Medicine Formula LC09
Placebo